These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2574937

  • 1. Expression of the Epstein-Barr virus (EBV) receptor on the surface of cells infected with EBV derived from nasopharyngeal carcinoma.
    Takimoto T, Umeda R.
    Acta Virol; 1989 Aug; 33(4):314-9. PubMed ID: 2574937
    [Abstract] [Full Text] [Related]

  • 2. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
    Takimoto T, Sato H, Ogura H, Miyawaki T, Glaser R.
    Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
    Lin CT, Lin CR, Tan GK, Chen W, Dee AN, Chan WY.
    Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q, Sato H, Murono S, Furukawa M, Yoshizaki T.
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma.
    Knox PG, Li QX, Rickinson AB, Young LS.
    Virology; 1996 Jan 01; 215(1):40-50. PubMed ID: 8553585
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clonal versus polyclonal Epstein-Barr virus infection in nasopharyngeal carcinoma cell lines.
    Lin CT, Chen W, Hsu MM, Dee AN.
    Lab Invest; 1997 Jun 01; 76(6):793-8. PubMed ID: 9194855
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y, Sheen TS, Lu J, Huang YT, Chen JY, Yang CS, Tsai CH.
    Lab Invest; 1998 Jun 01; 78(6):715-26. PubMed ID: 9645762
    [Abstract] [Full Text] [Related]

  • 19. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma.
    Yoshizaki T, Endo K, Ren Q, Wakisaka N, Murono S, Kondo S, Sato H, Furukawa M.
    Auris Nasus Larynx; 2007 Mar 01; 34(1):73-8. PubMed ID: 17129696
    [Abstract] [Full Text] [Related]

  • 20. Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT).
    Takimoto T, Ogura H, Sato H, Umeda R, Hatano M.
    J Natl Cancer Inst; 1985 Jan 01; 74(1):57-60. PubMed ID: 2982054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.